Article citationsMore>>
Ansell, S.M., Lesokhin, A.M., Borrello, I., Halwani, A., Scott, E.C., Gutierrez, M., et al. (2015) PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma. The New England Journal of Medicine, 372, 311-319.
https://doi.org/10.1056/NEJMoa1411087
has been cited by the following article:
-
TITLE:
N-Myc Inhibition: Advances in Neuroblastoma Treatment
AUTHORS:
Md Kamrul Hasan
KEYWORDS:
Neuroblastoma, N-Myc, PI3K/mTOR, PARP1, PD-L1, HAUSP
JOURNAL NAME:
CellBio,
Vol.6 No.3,
September
30,
2017
ABSTRACT: Neuroblastoma (NBL) is one
of the most common solid tumors and around 15% of cancer mortality in children.
Amplification of the N-Myc proto-oncogene is strongly correlated with
advanced disease and poor clinical outcome in NBL. Recent studies described
that ubiquitin-specific protease 7 (USP7; also known as HAUSP) interacts with
N-Myc, induces deubiquitination and subsequent stabilization of N-Myc that
in-turn potentiates N-Myc
function, and treatment with the HAUSP inhibitor (P22077) blocked such effects.
Related Articles:
-
Antonio Mirijello, Giovanni Addolorato, Raffaele Landolfi
-
Madiha Mahfoudhi, Khaled Khammassi, Imen Gorsane, Mounira El Euch, Sami Turki, Mamia Ben Salah, Taieb Ben Abdallah
-
Neelima Vidula, Andrew M. Evens, Irene B. Helenowski, Borko Jovanovic, Jane N. Winter, Jayesh Mehta, Seema Singhal, Stephanie F. Williams, Olga Frankfurt, Jessica K. Altman, Joanne Monreal, Leo I. Gordon
-
Mei Cao, Yansong Tu, Xiaoyan Jiang, Xuekun Wang, Yazhi Yang, Xiaoyan Zhang, Huaijun Tu, Jian Li
-
Amal Ismail, Ihsan Osman, Nazik Elmalaika Husain